Intratesticular serotonin affects steroidogenesis in the rat testis

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The effect of intratesticular administration of serotonin (5-HT), ketanserin (5-HT2 receptor antagonist), and 5,7-dihydroxytryptamine (5,7-DHT) (the neurotoxin that destroys serotoninergic neural elements) on steroidogenesis was studied in immature and adult rats. In adults, bilateral intratesticular injection of 5-HT resulted in a significant decrease in basal but not in hCG-stimulated testosterone secretion and in serum testosterone concentration, whereas ketanserin induced a significant rise in steroidogenesis 1 h post-treatment. There was no effect 1 day after administration of 5-HT or ketanserin, and 7 days after the injection of 5,7-DHT. In immature rats 1 day after bilateral testicular administration of ketanserin, basal testosterone secretion in vitro was significantly suppressed. In immature hemicastrates, local injection of 5-HT resulted (1 day post-treatment) in a significant rise in steroidogenesis while administration of 5,7-DHT decreased testosterone secretion 7 days after the injection of the neurotoxin. The results indicate that in adult rats 5-HT exerts a suppressive, whereas in immature rats, a stimulatory action on steroidogenesis occurs. Data also suggest that, in both age groups, the effect of 5-HT is mediated through 5-HT2 receptors. The observation that in immatures administration of the neurotoxin resulted in an effect similar to that found following the treatment with the receptor antagonist suggests that, in this age group, 5-HT derived from local neural elements might also be involved in the control of 5-HT on Leydig cell steroidogenesis.

Original languageEnglish
Pages (from-to)371-376
Number of pages6
JournalJournal of Neuroendocrinology
Volume10
Issue number5
DOIs
Publication statusPublished - May 1998

Fingerprint

Testis
Serotonin
Ketanserin
5,7-Dihydroxytryptamine
Testosterone
Neurotoxins
Injections
Age Groups
Serotonin 5-HT2 Receptor Antagonists
Leydig Cells
Therapeutics
Serum

Keywords

  • Ketanserin
  • Local control
  • Serotonin
  • Testis

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Intratesticular serotonin affects steroidogenesis in the rat testis. / Csaba, Zs; Csernus, V.; Gerendai, I.

In: Journal of Neuroendocrinology, Vol. 10, No. 5, 05.1998, p. 371-376.

Research output: Contribution to journalArticle

@article{11aef61f3fb74713809ab2e05ab6dbe5,
title = "Intratesticular serotonin affects steroidogenesis in the rat testis",
abstract = "The effect of intratesticular administration of serotonin (5-HT), ketanserin (5-HT2 receptor antagonist), and 5,7-dihydroxytryptamine (5,7-DHT) (the neurotoxin that destroys serotoninergic neural elements) on steroidogenesis was studied in immature and adult rats. In adults, bilateral intratesticular injection of 5-HT resulted in a significant decrease in basal but not in hCG-stimulated testosterone secretion and in serum testosterone concentration, whereas ketanserin induced a significant rise in steroidogenesis 1 h post-treatment. There was no effect 1 day after administration of 5-HT or ketanserin, and 7 days after the injection of 5,7-DHT. In immature rats 1 day after bilateral testicular administration of ketanserin, basal testosterone secretion in vitro was significantly suppressed. In immature hemicastrates, local injection of 5-HT resulted (1 day post-treatment) in a significant rise in steroidogenesis while administration of 5,7-DHT decreased testosterone secretion 7 days after the injection of the neurotoxin. The results indicate that in adult rats 5-HT exerts a suppressive, whereas in immature rats, a stimulatory action on steroidogenesis occurs. Data also suggest that, in both age groups, the effect of 5-HT is mediated through 5-HT2 receptors. The observation that in immatures administration of the neurotoxin resulted in an effect similar to that found following the treatment with the receptor antagonist suggests that, in this age group, 5-HT derived from local neural elements might also be involved in the control of 5-HT on Leydig cell steroidogenesis.",
keywords = "Ketanserin, Local control, Serotonin, Testis",
author = "Zs Csaba and V. Csernus and I. Gerendai",
year = "1998",
month = "5",
doi = "10.1046/j.1365-2826.1998.00217.x",
language = "English",
volume = "10",
pages = "371--376",
journal = "Journal of Neuroendocrinology",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Intratesticular serotonin affects steroidogenesis in the rat testis

AU - Csaba, Zs

AU - Csernus, V.

AU - Gerendai, I.

PY - 1998/5

Y1 - 1998/5

N2 - The effect of intratesticular administration of serotonin (5-HT), ketanserin (5-HT2 receptor antagonist), and 5,7-dihydroxytryptamine (5,7-DHT) (the neurotoxin that destroys serotoninergic neural elements) on steroidogenesis was studied in immature and adult rats. In adults, bilateral intratesticular injection of 5-HT resulted in a significant decrease in basal but not in hCG-stimulated testosterone secretion and in serum testosterone concentration, whereas ketanserin induced a significant rise in steroidogenesis 1 h post-treatment. There was no effect 1 day after administration of 5-HT or ketanserin, and 7 days after the injection of 5,7-DHT. In immature rats 1 day after bilateral testicular administration of ketanserin, basal testosterone secretion in vitro was significantly suppressed. In immature hemicastrates, local injection of 5-HT resulted (1 day post-treatment) in a significant rise in steroidogenesis while administration of 5,7-DHT decreased testosterone secretion 7 days after the injection of the neurotoxin. The results indicate that in adult rats 5-HT exerts a suppressive, whereas in immature rats, a stimulatory action on steroidogenesis occurs. Data also suggest that, in both age groups, the effect of 5-HT is mediated through 5-HT2 receptors. The observation that in immatures administration of the neurotoxin resulted in an effect similar to that found following the treatment with the receptor antagonist suggests that, in this age group, 5-HT derived from local neural elements might also be involved in the control of 5-HT on Leydig cell steroidogenesis.

AB - The effect of intratesticular administration of serotonin (5-HT), ketanserin (5-HT2 receptor antagonist), and 5,7-dihydroxytryptamine (5,7-DHT) (the neurotoxin that destroys serotoninergic neural elements) on steroidogenesis was studied in immature and adult rats. In adults, bilateral intratesticular injection of 5-HT resulted in a significant decrease in basal but not in hCG-stimulated testosterone secretion and in serum testosterone concentration, whereas ketanserin induced a significant rise in steroidogenesis 1 h post-treatment. There was no effect 1 day after administration of 5-HT or ketanserin, and 7 days after the injection of 5,7-DHT. In immature rats 1 day after bilateral testicular administration of ketanserin, basal testosterone secretion in vitro was significantly suppressed. In immature hemicastrates, local injection of 5-HT resulted (1 day post-treatment) in a significant rise in steroidogenesis while administration of 5,7-DHT decreased testosterone secretion 7 days after the injection of the neurotoxin. The results indicate that in adult rats 5-HT exerts a suppressive, whereas in immature rats, a stimulatory action on steroidogenesis occurs. Data also suggest that, in both age groups, the effect of 5-HT is mediated through 5-HT2 receptors. The observation that in immatures administration of the neurotoxin resulted in an effect similar to that found following the treatment with the receptor antagonist suggests that, in this age group, 5-HT derived from local neural elements might also be involved in the control of 5-HT on Leydig cell steroidogenesis.

KW - Ketanserin

KW - Local control

KW - Serotonin

KW - Testis

UR - http://www.scopus.com/inward/record.url?scp=0031799821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031799821&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2826.1998.00217.x

DO - 10.1046/j.1365-2826.1998.00217.x

M3 - Article

C2 - 9663651

AN - SCOPUS:0031799821

VL - 10

SP - 371

EP - 376

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

SN - 0953-8194

IS - 5

ER -